As a new type foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has built a "1+2+3+4=1" service system and can supply acetyl octapeptide sourced from multiple well-known original manufacturers.
As a technology-driven foreign trade enterprise, HiSiaddi has repeatedly collaborated with factories on technology conversion and accurately captured market demands to propose formula optimization solutions and application improvement suggestions for acetyl octapeptide. Below is a consultation case of HiSiaddi on acetyl octapeptide formula optimization.
If you need more formula optimization consultation services, please contact HiSiaddi customer service.
The purchaser is SwissDerma Research AG, headquartered in the biomedical innovation park of Geneva, Switzerland. Founded in collaboration with the skin physiology laboratory of the University of Geneva’s School of Pharmacy, it has specialized in R&D and manufacturing of premium medical aesthetic serums and medical repair stock solutions for nearly 30 years. Its products are exclusively supplied to high-end private medical aesthetic institutions and pharmacy chains across Switzerland, Luxembourg and Germany. Its flagship dynamic wrinkle repair firming serum relies on Acetyl Octapeptide (SNAP-8, CAS: 868844-74-0), complying with EU cosmetic raw material CPNP control standards and Swiss SCCS safety assessment specifications.
The client previously sourced high-purity acetate salt acetyl octapeptide directly from Spain’s Lipotec all year round with a stable annual purchase volume of 3.8kg, split into 2.9kg for mass production feeding and 0.9kg for new product formula R&D samples. Faced with annual price hikes of local European raw materials and a 110-day extended production lead time from the original supplier, the client selected a domestic Chinese peptide manufacturer to supply 3.8kg acetate salt acetyl octapeptide after sample screening. The goods arrived at the Swiss production plant via international cold chain air freight and were stored in warehouses.
However, mass production failures emerged continuously after the raw material was formally used for firming serum formulation: fine white flocculent precipitates formed after the stock solution stood at room temperature for 72 hours, oil-water separation occurred after 15 days of storage, the material turned from transparent light yellow to dark brown, and the anti-wrinkle efficacy measured via in vitro skin testing dropped by 42% compared with the original imported raw material. The qualified product rate for mass production batches plummeted from 96.8% (using original imported raw materials) to 47.2%, forcing two serum production lines to suspend operation temporarily, delaying the new product launch plan. Direct economic losses from raw material waste, idle production lines and discarded packaging materials amounted to 26,200 Swiss Francs.
The domestic supplier could only make minor adjustments to feeding ratios within its own synthetic process. Restricted by limitations in solid-phase synthesis routes, purification processes and salt formation control technologies, it could not trace root causes of failures from both raw material origin and the client’s formula system. Recommended by the Swiss Fine Chemical Raw Materials Association, the client fully entrusted Shanghai HiSiaddi Technology as a third-party technical foreign trade service provider. A special team consisting of internal peptide synthesis engineers and cosmetic formula R&D specialists resolved technical difficulties one by one across four segments: raw material impurity tracing, synthetic purification improvement, client-side formula system optimization and mass production process rectification. After optimized raw materials were re-supplied with supporting formula implementation guidance, a long-term fixed customized purchase framework for an annual volume of 3.8kg was subsequently signed.
Product specifications: Medical cosmetic grade acetate salt acetyl octapeptide white freeze-dried powder, vacuum light-proof sealed aluminum foil packaging, with batch-by-batch bilingual COA quality inspection reports, original HPLC spectra, endotoxin test sheets and SDS chemical safety data sheets.
The domestic manufacturer’s incomplete ion exchange process during acetate salt conversion left unremoved residual trifluoroacetic acid (TFA) measured at 326ppm, exceeding the client’s formula tolerance limit of 200ppm. Loose control over amino acid coupling conversion rates during solid-phase synthesis generated multiple short-chain missing peptide impurities, with the highest single hetero-peptide content reaching 0.32%, surpassing the client’s internal control limit of ≤0.1%.
As a strong acidic substance, residual TFA disrupts the original pH balance of the serum formula system after compounding. Trace hetero-peptides cannot fully miscible with polyols and plant extracts in the formula, slowly agglomerating to form white flocculent precipitates during room-temperature storage. Meanwhile, trace residual heavy metal catalysts accelerate peptide oxidation during storage, gradually turning the material brown and yellow and drastically reducing stability.
The client’s original emulsification system was formulated based on the 6%~9% acetate content range of European imported raw materials. The domestic batch recorded an acetate content of 12.7%, causing excessive anions that triggered charge antagonism reactions with cationic emulsifiers and cationic preservatives in the formula, breaking the original O/W oil-in-water emulsification balance. Long-term static storage of the serum leads to gradual oil-water phase separation, with floating oil on the upper layer and turbid sediment at the bottom.
Freeze-dried powder of European imported acetyl octapeptide features loose texture and fast dissolution speed. The client’s mass production workshop adopted a fixed feeding method: direct addition to the water phase at room temperature under stirring. By contrast, pre-optimized domestic raw material powder features dense texture and slow dissolution speed. Room-temperature feeding easily causes local agglomeration of wrapped dry powder that cannot fully disperse and dissolve. Undissolved peptide particles suspend in the stock solution, posing hidden precipitation risks and causing uneven distribution of active ingredients, resulting in inconsistent anti-wrinkle efficacy and overall sharp attenuation of activity in finished products.
The client added peptide raw materials after heating to 75°C during homogenization and emulsification, while acetyl octapeptide has a critical temperature tolerance limit of ≤50°C. Prolonged high-temperature environments break peptide bonds via hydrolysis, degrading effective active components and drastically reducing finished product skincare efficacy.
HiSiaddi’s special technical team implemented solutions across three modules: raw material side rectification, client-side formula fine-tuning and production process optimization, with parallel control samples retained to verify rectification effects item by item.
We coordinated upstream peptide factories to upgrade the full solid-phase synthesis and ion exchange workflow: First, optimize each step of amino acid coupling processes and apply real-time ninhydrin color development monitoring of coupling conversion rates; unqualified intermediates are re-fed to reduce generation of missing peptide by-products at the synthetic source. Second, upgrade anion exchange resin columns and adopt segmented gradient water washing to remove residual TFA, with finished products testing negative for TFA. Crude products are further purified via C18 reverse-phase chromatographic grading separation with separate collection of main peak fractions, controlling maximum single missing peptide impurities within 0.068% and raising HPLC main purity to 99.38%, fully meeting the client’s internal raw material control standards. Meanwhile, the salt formation process was precisely regulated to stabilize acetate content within the 7.2%~8.5% range, matching the client’s original formula design parameters.
HiSiaddi formula engineers remotely connected with the Swiss R&D laboratory to conduct fine-tuning without altering core functional raw materials of the original formula:
1. Add 0.12% disodium EDTA chelating agent in trace amounts to complex trace heavy metal ions introduced by raw materials and prevent heavy metal-catalyzed oxidative discoloration.
2. Slightly adjust emulsifier ratios by reducing cationic emulsifier dosage by 0.3% and supplementing a small amount of nonionic compound emulsifiers to eliminate charge conflicts caused by excessive acetate and stabilize the oil-water emulsification system.
3. Optimize the system buffer system by adding trace citric acid-sodium citrate buffer salts to stabilize the finished serum pH at 4.8~5.2, the optimal stable pH range for acetyl octapeptide, avoiding precipitation triggered by pH imbalance.
HiSiaddi compiled an English-German bilingual Operation Guidance Document for Mass Production Feeding of Acetyl Octapeptide and redesigned dissolution steps: pre-wet peptide dry powder with low-temperature deionized water (20~25°C, pH pre-adjusted to 5.0) specified in the formula, stir slowly for 30 minutes until powder fully dissolves before mixing into the main ingredient system to eliminate dry powder agglomeration and suspension. Feeding sequence in the workshop was optimized simultaneously: peptide solution is added to the material body only after emulsification cools below 48°C to avoid high-temperature hydrolysis and activity loss risks.
The client’s existing 1.7kg non-compliant raw material inventory was returned to the factory in batches for secondary purification using optimized ion exchange and chromatographic refining processes. After full-item re-testing confirmed compliance, the purified raw materials were vacuum light-proof repackaged and shipped to the Swiss factory together with new batches, drastically cutting client losses from scrapped raw materials.
1. The first batch of 2.1kg rectified customized acetyl octapeptide was air-freighted to Switzerland. Three consecutive mass production batches of firming serum passed all stability tests: no flocculent precipitation, stratification or discoloration after 90 days of room-temperature storage, with transparent and homogeneous material maintained. In vitro cellular activity testing confirmed anti-wrinkle efficacy restored to the level of original imported raw materials, and the qualified mass production rate rebounded to 96.5%. The two suspended production lines resumed operation smoothly, and the delayed anti-wrinkle serum launched on schedule across Swiss premium medical aesthetic channels, successfully recovering the 26,200 Swiss Francs of economic losses. Calculations showed overall comprehensive procurement unit prices for domestic raw materials dropped by 35.2% compared with Spanish original sources, and total delivery lead time was shortened from 110 days to 39 days.
2. Two months after rectification implementation, SwissDerma Research AG officially signed a long-term procurement cooperation framework for an annual volume of 3.8kg with HiSiaddi, agreeing to split production into 5 batches as required throughout the year with raw materials manufactured per the finalized synthetic, purification and salt formation process standards established in this project. All subsequent compound active peptide raw materials for the client’s new product R&D (copper peptide, pentapeptide, etc.) were entrusted to HiSiaddi for customized development and technical implementation. HiSiaddi established exclusive raw material files for the client and tracked updates to EU and Swiss cosmetic regulations in real time to optimize raw material indicators in advance.
3. Leveraging this successful Swiss premium cosmetic rectification case and the client’s local Swiss beauty industry resources, HiSiaddi successfully onboarded two mid-to-high-end clients: a skincare research institute in Liechtenstein and a premium medical aesthetic raw material laboratory in Munich, Germany, replicating the integrated technical service model of "raw material process rectification + formula optimization + production implementation guidance" to secure multiple customized peptide foreign trade orders.
There are obvious process gaps between general daily chemical mass-production grade and European salon-specific high-purity acetate grade acetyl octapeptide in ion exchange, impurity control and acetate precision. Most domestic peptide manufacturers focus mass production on low-cost TFA salt general-grade products with immature acetate conversion processes, easily triggering hidden raw material hazards including excessive residual solvents, out-of-control acetate content and over-limit trace hetero-peptides. European mid-to-high-end cosmetic brands rely on imported raw materials to form mature fixed formulas and mass production operation specifications. Deviations in physical and chemical parameters of domestic raw materials render original formulas and production processes incompatible, and overlapping dual problems directly trigger mass production failures for end products.
Moving beyond the inherent model of traditional foreign trade limited to raw material intermediary trading, HiSiaddi centers on dual core technologies of peptide synthesis and cosmetic formula application to connect full workflows of upstream raw material synthetic purification technical renovation, midstream formula system optimization and downstream factory mass production process guidance. We resolve technical failures bidirectionally from raw material origins and end application perspectives, helping overseas mid-to-high-end clients avoid production line shutdowns and huge economic losses from scrapped products. Supported by professional technical capabilities, we bind high-quality European premium end-user resources and support domestic high-end peptide raw materials to steadily enter European premium medical aesthetic raw material supply chains, emerging as a key technology-driven foreign trade service provider for domestic fine cosmetic raw materials going global.
If you need more formula optimization consultation services, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
